Dr. Bommakanti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
701 Park Ave
Minneapolis, MN 55415Phone+1 612-873-6369Fax+1 612-904-4341- Is this information wrong?
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2008 - 2011
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2005 - 2008
- Tulane University School of MedicineClass of 2005
Certifications & Licensure
- MN State Medical License 2009 - 2024
- WI State Medical License 2007 - 2023
- LA State Medical License 2011 - 2012
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsPhase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumors.Satya V. Bommakanti, Arkadiusz Z. Dudek, Amit Khatri, Mark N. Kirstein, Purvi Gada> ;American Journal of Clinical Oncology. 2011 Dec 1
- 8 citationsCase reports: efalizumab-associated lymphoproliferative disease.Satya Bommakanti, Amol Patil, Camellia Eshoa, Christopher R. Chitambar> ;Journal of Drugs in Dermatology. 2007 Jun 1
Hospital Affiliations
- Hennepin HealthcareMinneapolis, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: